MR
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
27.673
Exchange
XNAS - Nasdaq
15.7 B
Last period Assets ,USD
831%
Assets has increased in 5 years
What is Assets ?
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
See also Moderna
Company Analysis
MRNA valuation, rating, competitors, insights and company profile
Eyestock Rating
MRNA financial analysis by Eyestock methodology
Valuation
MRNA valuation using historical relative method
Statements
MRNA Income Statements, Balance Sheet and Cash Flow Statements
Dividends
MRNA dividend yield and annual dividend
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
Moderna`s Assets for the period ended 2024-06-30 are 15.7 B USD
